CLINICAL_TRIALS
trial_result
· 2018-10-26
Clinical Trial Update: PK/PD of High Dose Pip/Tazo in Obese Patients [NA]
Summary
Clinical trial update on pharmacokinetics/pharmacodynamics of high-dose piperacillin/tazobactam in obese patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Loma Linda University | Conditions: Obesity | NA | Status: COMPLETED | Results posted: 2018-10-26